Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

HRTXHRTX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in HERON THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.3M shares of HRTX (HERON THERAPEUTICS INC), worth $567,539 as of 2026-Q2. The position was increased (+25.8% shares).

Current Value

$567,539

Current Shares

1.3M

Total Value Change

-$434,856

Total Shares Change

+674,594

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+25.8%
$567,5390.0%$0.43
20
2026-Q1
Increased
1.1M
+6.8%
$845,6610.0%$1.15
27
2025-Q4
Decreased
989,796
-25.3%
$1.3M0.0%$1.35
0
2025-Q3
Increased
1.3M
+27.0%
$1.7M0.0%$1.27
32
2025-Q2
Increased
1M
+1.4%
$2.2M0.0%$2.14
26
2025-Q1
Increased
1M
+57.0%
$2.3M0.0%$2.26
37
2024-Q4
New
655,160
-
$1M0.0%$1.51
35

Other major holders of HRTX: FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used